Pharmacy Benefit Managers (PBMs) in Florida are faced with new regulatory requirements that necessitate action before the impending deadline of January 1, 2024. Under Florida’s newly minted Prescription Drug Reform Act, entities desiring to provide PBM services after said date must secure a license as a Third-Party Administrator (TPA).
This legislative development comes as part of an industry-wide push for greater oversight and regulation of PBM operations, with the aim of advancing the care of patients. The restructuring of PBMs into TPAs is anticipated to have a transformative impact on how these entities interact within the healthcare system at large.
Those entities intending to provide PBM services post-January 1, 2024, but fail to comply with the requisite licensing requirements, risk facing punitive fines. The details of such sanctions are yet to be detailed, but the state’s commitment to enforcing this new legislation is clear.
Akerman LLP’s Health Law Rx underscores the importance of proactive compliance with these new statutory licensing requirements to circumvent punitive measures. The firm strongly advises existing PBMs and those considering entering the field to evaluate their licensing needs, regulatory requirements, and potential business consequences of non-compliance.
The Florida Prescription Drug Reform Act and its licensing requirements exemplify the broader campaign for heightened oversight of PBMs. For Florida PBMs, the clock is ticking; swift action is necessary to navigate these new regulatory landscapes with minimal disruption to their operations and patient care.
For more information regarding the new legislation and its impact, visit JD Supra.